000			01950 a2200553 4500
005			20250517192342.0
264		0	_c20181026
008			201810s 0 0 eng d
022			_a1528-1167
024	7		_a10.1111/epi.13978 _2doi
040			_aNLM _beng _cNLM
100	1		_aVanhoof-Villalba, Stephanie L
245	0	0	_aPharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy. _h[electronic resource]
260			_bEpilepsia _c02 2018
300			_a358-368 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAnticonvulsants _xpharmacology
650	0	4	_aAtrioventricular Block
650	0	4	_aBehavior, Animal
650	0	4	_aBradycardia
650	0	4	_aCarbamates _xpharmacology
650	0	4	_aChannelopathies
650	0	4	_aDeath, Sudden
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Resistance
650	0	4	_aDrug Resistant Epilepsy _xdrug therapy
650	0	4	_aElectroencephalography
650	0	4	_aEpilepsy _xdrug therapy
650	0	4	_aGene Expression Profiling
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aKCNQ Potassium Channels _xagonists
650	0	4	_aKCNQ1 Potassium Channel _xgenetics
650	0	4	_aKCNQ2 Potassium Channel _xgenetics
650	0	4	_aKCNQ3 Potassium Channel _xgenetics
650	0	4	_aKv1.1 Potassium Channel _xgenetics
650	0	4	_aMice
650	0	4	_aNerve Tissue Proteins _xgenetics
650	0	4	_aPharmacogenetics
650	0	4	_aPharmacogenomic Testing
650	0	4	_aPhenylenediamines _xpharmacology
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aTranscriptome
700	1		_aGautier, Nicole M
700	1		_aMishra, Vikas
700	1		_aGlasscock, Edward
773	0		_tEpilepsia _gvol. 59 _gno. 2 _gp. 358-368
856	4	0	_uhttps://doi.org/10.1111/epi.13978 _zAvailable from publisher's website
999			_c27912930 _d27912930